Brief: Synlogic announces synthetic biotic for gout developed in partnership with Ginkgo Bioworks
11/08/2022 12:27
Aug 11 (Reuters) - Ginkgo Bioworks Holdings Inc DNA.N :
* SYNLOGIC ANNOUNCES SYNTHETIC BIOTIC FOR GOUT DEVELOPED IN
PARTNERSHIP WITH GINKGO BIOWORKS
Source text for Eikon: ID:nPn3vG4Wza
Further company coverage: DNA.N
Recent news on Synlogic
See all newsBrief: Synlogic Receives Letter From Nasdaq Listing Qualifications Department On Nov 21 - SEC Filing
Brief: Synlogic Inc Files For Mixed Shelf Of Up To $150 Million – SEC Filing
Synlogic Inc reports results for the quarter ended September 30 - Earnings Summary
Synlogic Inc expected to post a loss of 10 cents a share - Earnings Preview
Synlogic Inc reports results for the quarter ended in January - Earnings Summary